Minocycline 1 MG Oral Powder — RxCUI 351121
RxNorm drug concept · Semantic clinical drug
RxCUI 351121
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI351121
Official nameMinocycline 1 MG Oral Powder
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asminocycline 1 MG (as minocycline hydrochloride) Oral Powder; minocycline HCl 1 MG Oral Powder
FDA products mapped1
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Minocycline Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Amzeeq is specifically approved to treat inflammatory acne lesions — the red, swollen bumps — in people 9 years and older with moderate to severe acne. It's not for blackheads or w...
- What exactly is Amzeeq used for — is it just for acne?
- Shake the can well before each use, then dispense a small amount — roughly the size of a cherry — onto your fingertips and rub it gently into your acne-affected skin. If you have b...
- It's worth taking seriously. The propellant that pushes the foam out of the can is flammable, so you should stay away from open flames, candles, or cigarettes while you're applying...
🕸️ Concept Web — How Minocycline 1 MG Oral Powder Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Minocycline 1 MG Oral Powder
RxCUI 351121 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Minocycline
6980IN
-
Minocycline
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Arestin
352444BN
-
Arestin
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Minocycline Oral Powder
378771SCDF -
Minocycline Oral Powder Product
1295397SCDG -
Minocycline Oral Product
1164754SCDG -
Minocycline Oral Powder [Arestin]
403110SBDF -
Arestin Oral Powder Product
1296449SBDG -
Arestin Oral Product
1170112SBDG -
Oral Powder
346289DF -
Oral Powder Product
1294711DFG - +1 more in this family
-
Minocycline Oral Powder
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Minocycline 1 MG
353349SCDC -
Minocycline 1 MG Oral Powder [Arestin]
351974SBD -
Minocycline 1 MG [Arestin]
575725SBDC
-
Minocycline 1 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Minocycline 1 MG
SCDC · 353349 -
Minocycline Oral Powder
SCDF · 378771 -
Minocycline Oral Powder Product
SCDG · 1295397 -
Minocycline Oral Product
SCDG · 1164754
Brand-Name Concepts
-
Minocycline 1 MG Oral Powder [Arestin]
SBD · 351974 -
Minocycline 1 MG [Arestin]
SBDC · 575725 -
Minocycline Oral Powder [Arestin]
SBDF · 403110 -
Arestin Oral Powder Product
SBDG · 1296449 -
Arestin Oral Product
SBDG · 1170112 -
Arestin
BN · 352444
📦 FDA Products & Package NDCs
1 product · 3 package NDCs
3 package NDCs map to RxCUI 351121 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 65976-0100-01 | 1 POWDER in 1 POUCH (65976-100-01) | Arestin | OraPharma, Inc. | 2011-03-21 |
| 65976-0100-12 | 1 POUCH in 1 BOX (65976-100-12) / 1 TRAY in 1 POUCH / 12 PO... | Arestin | OraPharma, Inc. | 2011-03-21 |
| 65976-0100-24 | 2 POUCH in 1 BOX (65976-100-24) / 1 TRAY in 1 POUCH / 12 PO... | Arestin | OraPharma, Inc. | 2011-03-21 |
Observed labelers:
OraPharma, Inc. (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.